Hospital Medical School, London
Hopkins' contributions t o nutrition, particularly with respect t o the vitamins. Later, however, I came to realize the breadth of his work and thinking and the influence that he exerted on the development of many other aspects of biochemistry.
My lecture this evening will be divided into several sections. First. I will present a brief historical account of the developnient of our present knowledge of protein phosphorylation. After that I would like to discuss the protein kinases, which constitute key elements of the protein phosphorylation-dephosphorylation machinery. Then, briefly, I will consider what is known about the effect of phosphorylation on the structure and function of proteins. This will lead into a section on the biological significance of protein phosphorylation, which is the part most closely related to the title of the lecture. Finally, I will close by attcnipting to forecast future developments in tlie field.
Historv of protein phosphorvlation
A textbook of biochemistry published in 1947 (Hawk ct a/.. 1947) had this to say about phosphoproteins, 'The phosphorus in these proteins is bound in ester linkage to the hydroxyamino acids, serine and threonine . . . .
Examples of pliosplioproteins include casein from milk, ovovitellin from egg yolk. and other proteins associated with the feeding of the young.' The nutritional function of phosphoproteins is still considered to be important, of course, but these proteins are now known to have additional roles. One of these relates to the formation of phosphoproteins as transient intermediates involved in the mechanism of action of certain enzymes and transport proteins: but the most noteworthy function of phosphoproteins is their role in dynamic regulatory processes within the cell. It is with the last aspect that this lecture will be conce rned.
A realization that the phosphorylation and dephosphorylation of cellular proteins constitutes a major regulatory process was relatively slow in developing. Unlike the sudden and universal acceptance of allosteric control, which followed tlic exciting revelations by Monod and his co-workers (Monod etal., 1963) in the mid-l960s, a general appreciation of tlie significance of phosphorylationdephosphorylation occurred only after several decades of work carried out in a number of different laboratories. Let us go back to early studies on glycogen metabolism, which served to set the stage for the development of this field.
I n tlie early 1940s the Coris' and Arda Green showed that the enzyme phosphorylase exists in two forms. which they designated as phosphorylase b and phosphorylase a (Cori & Green, 1943; Cori & Cori, 1945) . Phosphorylase b Vol. 13 81 DOCTOR EDWIN G. KREBS required high concentrations of 5'-AMP for activity and was thought to be a physiologically inactive form, whereas phosphorylase a was highly active in the absence of cofactors, and was considered t o be the active form of the enzyme. The Coris' showed that the two forms of phosphorylase are interconvertible in the intact cell, and they postulated that the interconversion reactions constituted a physiologically significant regulatory mechanism. It was difficult for them t o be very precise as t o how the regulatory system would work, because at that time the existence of a separate biosynthetic pathway for glycogen formation was unknown, and it was believed that phosphorylase catalysed glycogen biosynthesis as well as glycogen degradation. Certi Cori died during tlie 1950s, but Carl Cori passed away only this past October. As my former mentor he had a major influence on my decision to follow a career in biochemistry rather than internal medicine, and at this time I would like to pay tribute to him. Cori, like Hopkins, was one of the giants of 20th century biochemistry. His active research career overlapped that of Hopkins and those of all of us here today. An understanding of the mechanism involved in the 3 8 I4
BIOCHEMICAL SOCIETY TRANSACTIONS interconversion reactions of phosphorylase came approximately 10 years after their discovery, when, in the 1950s, independent work on liver phosphorylase by Earl Sutherland (also a Cori student) and muscle phosphorylase by E. H . Fischer and myself (Fischer & Krebs, 1955; Sutherland & Wosilait, 1955) showed that enzymecatalyscd protein phosphorylation-dephosphorylation reactions were involved. The enzyme catalysing the phosphorylation reaction was named phosphorylase kinase and that catalysing the dephosphorylation step was called phosphorylase phosphatase (Fig. 1) . In 1959, evidence was obtained that phosphorylase kinase, like phosphorylase itself, is also regulated by phosphorylation-dephosphorylation and that cyclic AMP is somehow involved in the conversion of the non-activated form of the kinase t o a more active form (Krebs et al., 1959) . In the early 1960s, Joseph Larner and his collaborators showed that the then recently discovered enzyme, glucogen synthase, constituted a third enzyme that undergoes reversible phosphorylation--dephosphorylation (Friedman & Larner, 1963) . To this point the three known examples of enzyme regulation by phosphorylation-dephosphorylation, phosphorylase, phosphorylase kinase and the synthase, all involved glucogen metabolism, and it was considered by some that perhaps this was an esoteric type of control system restricted t o one limited area of carbohydrate metabolism. Preliminary reports involving possible examples of phosphorylatable enzymes in pathways other than those of glycogen metabolism appeared in the mid-1960s (Rizak, 1964; Medicino et al., 1966) , but it was not until 1969, with the finding from Lester Reed's laboratory that pyruvate dehydrogenase is regulated by phosphorylationdephosphorylation (Linn et al., 1 9 6 9~. b) , that the field broke out of the more restricted area. This event more or less coincided with the finding that the enzyme that catalyses the phosphorylation and activation of phosphorylase kinase is a cyclic AMP-dependent protein kinase having a relatively broad specificity, thus making it a likely mediator for the many functions of cyclic AMP (Walsh et al., 1968; Kuo & Greengard, 1969) . A period of rapid growth in the number of reports of enzymes undergoing phosphorylation ensued, and by 1984 at least 50 enzymes in this category were known. It should be emphasized, however, that some reports of enzymes 'regulated' by phospliorylation are based solely on work in vitro and niany of them do not meet the criteria that need to be satisfied before it is established that a given enzyme phosphorylation is physiologically significant (Krebs et al., 1985) . In addition, the protein kinases themselves, essentially all of which undergo autophosphorylation reactions, are included in this number. and in most instances there is n o known 
The protein kinascs
If one considers the general process of protein phosphorylation-dephospliorylation as exemplified by the activation-inactivation cycle of phosphorylase ( Fig. 1 As we will see in a moment, the protein kinases are usually classified and named o n the basis of what regulates their activities. As to how many protein kinases exist, I think it is much too early t o tell, but some idea as t o their number and diversity can be seen in Table 1 and Table 2 .
Perhaps the best-characterized protein kinases are the family of cyclic AMP-dependent kinases. These exist in several isoenzymic forms designated as type I. type II and type 11'. These enzymes share a common catalytic subunit and all of them exhibit the same specificity. There is also a cyclic GMP-dependent protein kinase. No isoenzymic forms for this kinase have been described. A very important group is made up of the Ca2+ (calmodu1in)-dependent protein kinases. These are distinct enzymes having different specificities. Of the enzymes in this category listed here, I have already mentioned phosphorylase kinase, an enzyme that is regulated not on1 by pliosphorylation~deplios-phorylation but also by Cax ions. Then there are two types of myosin light chain kinase (MLCK), an enzyme first discovered by Pircs et al. (1974) . Finally, there is a sonicwhat less specific Ca2+ (calmodu1in)-dependent protein kinase, which is designated as the multifunctional kinasc by many investigators. This latter enzyme was probably first detected by Schulnian & Grcengard (1978) in brain and other tissues and by Payne & Soderling (1980) as a glycogen synthase kinase. Another Ca2+ ion-dependent protein serine kinase, but one that does not utilize calmodulin, is protein kinase C, discovered by Niskizuka and co-workers (Inoue et al., 1977; Takai et al., 1977) 
Casein kinase 11
Glycogen synthase kinases 3 a n d 4 Growth-associated protein kinase Others very much in the news nowadays (for a review, see Nishizuka, 1983) . The principle effector controlling the activity of protein kinase C is diacylglycerol. Phorbol esters have been shown t o mimic diacylglycerol in this respect (Castagna ct al., 1982) . There are other protein serine kinases regulated by various effectors including doublestranded RNA, haeniin, and metabolites involved in the pyruvate dehydrogenase reaction. Finally, there is a fairly large group of protein serine kinases for which no regulatory agents are known. These so-called 'independent' protein kinases include those listed in Table 1 as well as a number of others. It is not unlikely that regulators for iiiany of the enzymes in this group will eventually be discovered, o r it may turn out that these enzymes are regulated by other kinases.
I n 1979 it was recognized that there are protein kinases ( Table 2 ) that catalyse the phosphorylation of tyrosine residues i n proteins (for a review, see Sefton & Hunter, 1984) . The first of thcm to be described was pp6OSm, the protein product of the Rous sarcoma oncogene, src. Later it was found that at least six other viral oncogenes also encode protein tyrosine kinases, as d o their cellular counterparts. All of the enzymes in this group are structurally related t o the ~~6 0 "~.
A second major group o f protein tyrosine kinases consist of a set of hormones o r growth factor receptors, four of which are currently known; the enzynies in this group are the insulin, epidermal growth factor (EGF), platelet-derived growth factor (PDGF) In this model the catalytic subunits of the cyclic AMPdependent protein kinase are shaded, as are the catalytic domains of the cyclic GMP-dependent protein kinase chains. Regulatory subunits or regulatory domains are unshaded. On binding of cyclic nucleotides dissociation and activation of the inactive holoen~yme occurs with the cyclic AMP-dependent kinase, but with the cyclic GMPdependent enzyme actication occurs without dissociation. In each case 2 mol of cyclic nucleotide are bound per mol of regulatory subunit or regulatory domain. Corbin ct a/. (1978) were the first t o show the correct stoichiometry for cyclic nucleotide binding to these enzymes.
Phosphorylase kinase (Table 2 ) is a large molecule made up of four different types of subunits. This enzyme has an a4/34y464 structure. The y-subunit is the catalytic subunit of this kinase; its M, value is 40 000. the same as that of the catalytic subunit of the cyclic AMP-dependent protein kinase. The 6-subunit is calmodulin. as shown by Cohen el al. (1978) . The a-and /3-subunits are involved in the activation of the enzyme by phosphorylation-dephosphorylation. In addition t o activation as a result of the binding of . 4 Let us look first at the cyclic nucleotide-binding domains of the cyclic AMP-dependent and cyclic GMPdependent protein kinases, which I will hereafter refer t o simply as the cA and CC kinases respectively (Fig. 3) . In Fig. 4 the catalytic subunit of the cA kinase is used as the basis for calculating alignment sources. The subunit has been divided more or less arbitrarily into three segments, each of which is compared with segments of other proteins lined up beneath it. Alignment scores of 17.3, 22.9 and 13.2 indicate very strong homology with the corresponding segments of the catalytic domain of the c C kinase (Takio et al., 1984) .
The catalytic or y-subunit of rabbit muscle phosphorylase kinase, sequenced by Erwin Reimann while on sabbatical leave in Kenneth Walsh's laboratory, is homologous t o the catalytic subunit throughout part of its structure but not in its C-terminal portion (Reimann et al., 1984) . The catalytic domian of rabbit skeletal muscle MLCK, which resides in the C-terminal half of that molecule, is homologous to the catalytic subunit (K. Takio, D. K . (Barker & Dayoff, 1982) . Not shown are comparisons with other oncogeneencoded protein tyrosine kinases or the EGF receptor. However, inasmuch as all of the protein tyrosine kinases whose sequences are known show homology with pp6Oflcc, they are all related to the catalytic subunit (reviewed in Sefton & Hunter, 1984) . It can be anticipated that tlie insulin receptor will also fall into this category. Phosphorylase kinase and MLCK are both regulated by CaZ+ and calmodulin, whereas the cA and cG kinases are regulated by cyclic nucleotides. It was hoped at first that a unique sequence, common to the first pair of en7ynies but lacking in the second, might stand out to help in the identification o f the calmodulin-binding site on these enLynies. At first glance this did not occur, although a very low degree of homology (alignment of 2.4) was found between the C-terminal segments of the y-subunit of phosphorylase kinase and MLCK. Other approaches were successful, however, in defining and localizing a calmodulin-binding site on the latter enzyme.
If skeletal muscle MLCK is partially degraded by using proteases one can obtain catalytically active fragments, as has also been demonstrated by Mayr & Heilmayer (1983) . The size and location in the molecule of some of the fragments generated by chyniotrypsin and trypsin are shown in Fig. 5 . With chymotrypsin a fragment is obtained that is calniodulin-independent and has a molecular mass of about 35 000 daltons. This fragment contains the catalytic domain (shaded), i.e. the protein homologous t o the catalytic subunit of the cA kinase, as well as having small portions which show n o honiology with the catalytic subunit of the cyclic AMP-dependent protein kinase. With trypsin one generates catalytically active calmodulin-dependent fragments having molecular masses of 40000 and 60000 daltons. These fragments extend almost all the way t o the C-terminus of MLCK and also have regions beyond the catalytic domain that extend toward the N-terminus. Based on these findings. it was tempting t o postulate that the calmodulin-binding site in MLCK resides somewhere in the non-catalytic portions of the tryptic fragments that are missing in the chymotryptic fragment, i.e. either at their N-terminal or C-terminal ends. The latter turned out to be the case.
Localization and definition of the calniodulin-binding site was finally determined by testing the ability of CNBr Upper bar represents intact MLCK in which the shaded portion is that part of the molecule homologous with the catalytic subunit of the cyclic AMP-dependent protein kinase. C-35K, an M,-35 000 fragment generated by using ehymotrypsin; T-40K, a n M,40 000 fragment generated by using trypsin; C-60K, an M,-60 000-fragment generated by using trypsin; M-13, the C-terminal peptide from MLCK generated by using cyanogen bromide.
Vol. 13 fragments of MLCK to inhibit MLCK activity under conditions in which added calmoddin is limiting. When a total CNBr digest of non-proteolysed MLCK was examined it was found to be inhibitory at low molar concentrations, halfmaximal inhibition inhibition occurring at a molarity of 4-5 nM, based o n the original MLCK concentration. A digest of a mixture of the 40 and 60 kilodalton tryptic fragments was similarly inhibitory. By contrast, the CNBr digest of the calmodulin-independent 35 kilodalton fragment showed a marked reduction in its ability t o inhibit activity, and the slight inhibition that was seen could have been due to a low level of contamination of the calmodulinindependent fragment with dependent fragment(s). When CNBr fragments from MLCK were exaniined individually, only one of them, fragment 13, consisting of the C-terminal 27 amino acids of the enLyme, was found to be inhibitory. Inhibition by this fragment, M-13, was only slightly less than that of the digest of intact MLCK. The adjacent fragment, M-12, or a mixture of M-l 1 and M-12, was not inhibitory. Donald Blumenthal from any laboratory has synthesized a peptide corresponding to M-13 and has determined that it is even more potent in inhibiting MLCK activity than M-13 generated by CNBr digestion. The lower inhibitory potency of M-13 relative to the synthetic peptide is probably due to modification of sensitive amino acid side chains in the peptide by the conditions used for CNBr digestion. Drs Blumenthal, Edelman, Takio and others involved in this work will be reporting on thc structure and properties of the calmodulin-binding site at tlie Biophysical Society Meeting in Baltimore in February (Blumenthal et al., 1985) .
Effect of phosphorylation on protein structure
For protein phosphorylation to function in a regulatory capacity it is clear that the introduction or removal of covalently bound phosphate must cause structural changes in protein substrates that in turn lead t o functional changes. How much d o we really know about the chemical nature of this process? The demonstration of functional changes accompanying phosphorylation has been the sine qua non among investigators for acceptance that a given protein phosphorylation event is of regulatory significance, and such changes are readily seen, but in only one instance is much known about structural changes that underlie functional change. This exception is for the original phosphorylation-dephosphorylation enzyme, namely glycogen phosphorylase.
As a result of X-ray crystallography studies o n the structure of phosphorylase b , carried out by Louise Johnson at Oxford University, and similar studies on the structure of phosphorylase a by Robert Fletterick and Neil Madsen in Canada, and their respective collaborators, we now have one example in which information is available with respect t o the actual structural change brought about by phosphorylation. In the conversion of phosphorylase b to phosphorylase a a single phosphate group is introduced on Ser-14, very close t o the N-terminus of each phosphorylase subunit, which contains 841 residues. Phosphorylation of the protein results in the formation of three new salt bridges, one of which is between the phosphate group and Arg-69 of the same subunit. Two of the salt bridges are intersubunit bridges. Fletterick & Madsen have calculated that the binding energy of these salt bridges is translated into a highly significant decrease in the allosteric constant for phosphorylase a as compared with phosphorylase b . They have spoken of the phosphate group as a 'covalently bound allosteric ligand', which, like 5'-AMP and other positive effectors, promotes a T to R conformational change (Sprang & Fletterick, 1980; N. B. Madsen, personal communication) .
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The majority of proteins that are regulated by phosphorylation-dephosphorylation are oligomeric proteins, which, like phosphorylase. are known t o be regulated by the non-covalent binding o f various ligands. It is not unlikely that the findings with respect to the effect of phosphorylation on phosphorylase can be extended to other systems regulated in this manner.
The biological significance of protein phosphorylation
Given the tremendous potential for the regulation of protein function provided by allosteric control involving non-covalently bound ligands, why is another regulatory mechanism such as phosphorylation-dephosphorylation needed? Investigators puzzling over this question have invoked a number of possible reasons. For example, some think of the various forms of regulation on a time scale and consider allosteric control as being rapid and transient, whereas regulation due t o protein phosphorylation is viewed as being slower and niore enduring. Disregarding these temporal considerations, I like t o think of the two control systems as having evolved to serve two different situations, allosteric control being primarily designed to handle signals arising from within the cell, whereas control by phosphorylation is geared to the handling of signals arising from outside the cell. According t o this general concept, messages carried by hormones and other extracellular stiniuli would be transmitted as a result of the phosphorylation o f key functional proteins ultimately responsible for the cellular functions known t o be affected by the various outside agents (Fig. 6 ). The idea that protein phosphorylation-dephosphorylation is largely concerned with the handling of external signals is in keeping with the fact that protein phosphorylation is much more abundant in eukaryotic cells than it is in prokaryotic cells, suggesting that the process evolved to meet the needs of more complex organisms in which extracellular signals are especially important. By contrast, allosteric control mechanisms are fully developed in prokaryotes.
Let us look at some of the spccit'ic systems in which protein phosphorylation serves such a function:
Systems in which cyclic AMP is involved. The prototypical model for the regulation of cellular activity by hormones is the cyclic AMP system (Fig. 7) . Here it is known that one group o f hormones, including, for example. adrenocorticotropin, glucagon, P-adrenergic catecholamines and the gonadotropins, acting through their specific receptors, stimulate adenylate cyclase, which leads t o elevated cyclic AMP levels. A second group of horinones, exemplified by adenoisine and a2 -adrenergic agents cause inhibition of adenylate cyclase leading t o decreased cyclic AMP levels. The changes in cyclic AMP concentration in turn alter the activity of the cyclic AMP-dependent protein kinase, thus far the only receptor protein defined for cyclic AMP in eukaryotic cells. Changes in the activity of the cyclic AMP-dependent kinase lead t o an increase or a decrease in the phosphorylation state of key cellular proteins. The last change then promotes some physiological A specific example of a cyclic AMP-niediated process involving protein phosphorylation is the classical glycogcnolytic cascade as it occurs in skeletal muscle stiniulated by adrenaline (Fig. 8) (Fig. 9 ). According to current concepts, many different extracellular agents. including, for example, niuscarinic cholincrgic hormones, a-adrenergic Iiorniones, 5-liydroxytryptaminc, histamine. and angiotensin trigger tlic breakdown of pliosphatidylinositol bisphosphatc and acceleration o f tlic Ptdlns cycle. This leads to elevated levels of two intracellular second messengers, inositol triphosphate and diacylglycerol. The first of. these niesscngcrs is responsible for the mobilization of free intracellular C;i2+ ions and the subsequent activation of a set of at least four Ca2+ (caliiiodu1in)-dependent protein kinases and one phosphoprotein phosphatase. Diacylglyccrol accumulation causes activation of protein kinasc C. These cnzynies then niodulate protein phosphorylation in a nicaningful nianner so as to produce tlie physiological effect of tlic hormone in question (for reviews. see Berridge. 1984 : Nishizuka, 1984 (Stull et ul., 1982) .
Mechanisnis oj' action of horniones whose receptors arc protein tyrosine kirmcs. The final system that I would like t o consider is the mechanism of intracellular transmission of signals generated by those hormones whose receptors are protein tyrosine kinases. When it became known that the EGF, PDGF, insulin and IGF-I receptors are all protein tyrosine kinases (reviewed in Hunter & Cooper, 1985) , it was generally assumed that the mechanism of action of this set of horniones would be elucidated quickly. The obvious inference was that appropriate cellular proteins, which could account for the plciotropic actions of these hormones, would soon be identified as substrates for the receptor kinases and that at last the long sought (particularly in reference to insulin) niechanisni of action would be solved. Several years have gone by, however, and investigators have not as yet identified any universally accepted substrates for the receptor protein tyrosine kinases. For this reason some investigators are now having doubts as t o whether or not the protein kinase activity of the receptors is really important. My own bias remains that it is very important. A catalytic function o f a protein is not a trivial property.
In work being carried out in my own laboratory, we have been guided by the hypothesis that protein tyrosine phosphorylation feeds into or regulates the much more abundant serine (threonine) phosphorylation that occurs in cells. This is illustrated using the insulin receptor as an example in Fig. 11 . One mechanism by which this might occur would be a 'mixed cascade' systeni in which a specific protein serine kinase or a phosphatase serves as a substrate for a protein tyrosine kinase. Activation of the kinase (or phosphatase) as a result of its being phosphorylated on a tyrosine residue could then lead t o alteration of serine phosphorylation within the cell. Support for a communication between protein tyrosine kinases and changes in protein serine phosphorylation has been obtained by a number of laboratories in intact cell systems. For example it is known that insulin stimulates the serine phosphorylation of proteins such as ribosomal protein S6, acetyl-CoA carboxylase, and ATP-citrate lyase. Insulin stimulates the dephosphorylation of other proteins such as glycogen synthase and pyruvate dehydrogenase. Despite a considerable amount of work, however, we have not been successful in reconstructing a mixed cascade system using isolated components. In this connection it is of interest, however, that at this meeting there is a report (Tavare cf al., 1985) that insulin stimulates the phosphorylation of acetyl-CoA carboxylase on serine residues in Triton extracts of placental membranes. Elucidation of the steps involved in this and other insulin-responsive cell-free systems should eventually lead t o an understanding of how tyrosine phosphorylation affects serine phosphorylation.
